Lilly teams up with J&J’s Synthes to find new bone healing solutions
This article was originally published in Scrip
Executive Summary
Eli Lilly and orthopaedic trauma specialist Synthes have agreed to develop bone healing products that combine Synthes's biomaterials with Lilly's drugs. The firms hope the collaboration will uncover new ways of treating fractures and osteoporosis. Financial terms of the deal were not disclosed.